 |
 |
Advances in genomics, molecular pharmacology, and proteomics provide tools to obtain a comprehensive picture of an individual's makeup. However, the amount of data these tools generate is rapidly outstripping the ability to properly analyze it and extract practical information about individuals and their responses to disease prevention or treatment.
Genetics Squared's Evolver TM technology successfully integrates diverse and voluminous data to produce implementable, predictive signatures. Our partners use these signatures to achieve improvements in personalized medicine through innovative diagnostic, prognostic, and therapeutic development. |
| Genetics Squared, evolving personalized medicine and Evolver are trademarks of Genetics Squared, Inc. |
|
|
 |
- May, 2008, Genetics Squared’s Chief Medical Officer Selected for the Sanford Project Advisory Council whose Recommendation will Influence $400 million research decisions
- May, 2008 Bill Worzel, Genetics Squared's CEO organized the annual conference GP Theory & Practice with Dr. Rick Riolo of the Center for the Study of Complex Systems at the University of Michigan and Dr. Terry Soule from the University of Idaho. Worzel presented the paper "A Population Based Study Of Evolutionary Dynamics In Genetic Programming" written with A.A. Almal and C.D.MacLean of Genetics Squared.
- January, 2008 Case Study: Using Genetics Squared’s EvolverTM Technology to Identify Predictive Biomarkers for Legionella pneumophila Pathogenicity
- September 2007 Poster (pdf) presented at the 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 17-20, Chicago. Schuren et al. Identification of predictive markers for Legionella pneumophila pathogenicity.
- June 1-5, 2007 Genetics Squared attended ASCO, American Society of Clinical Oncology, Chicago, Illinois
- May 15, 2007 Bill Worzel, President and CTO, facilitated elite, by invitation only, Genetic Programming Theory and Practice V workshop, May 17-19, 2007, Ann Arbor, MI more
- September 25, 2006 Genetics Squared Awarded $1.6 million from the 21st Century Job Fund read more
|
|
